Catalyst Wire Dossier Catalyst Wire Dossier

LEVULAN Photodynamic Therapy

5-aminolevulinic acid (ALA) for photodynamic therapy · DUSA Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LEVULAN Photodynamic Therapy, covering 2013-12-24 to 2013-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK) [Phase 2]

See pricing